Accelerate Diagnostics (NASDAQ: AXDX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.62) by 43.55 percent. This is a 493.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $3.03 million which missed the analyst consensus estimate of $3.45 million by 12.26 percent. This is a 1.85 percent increase over sales of $2.97 million the same period last year.